Emami Limited share price
NSE: EMAMILTD · ISIN INE548C01032
Key numbers
- Market cap
- ₹ 16,881 Cr
- Current price
- ₹ 389.25
- 52-week high / low
- ₹ 568 / 361
- Stock P/E
- 22.7
- Book value
- ₹ 67.0
- Dividend yield
- 3.08%
- ROCE
- 29.2%
- ROE
- 27.6%
- Debt to equity
- 0.06
- Sales growth (3 yrs)
- 3.7%
- Profit growth (3 yrs)
- 6.6%
- 1-year return
- -32.6%
About Emami Limited
Emami Limited, together with its subsidiaries, manufactures and markets personal and healthcare products in India and internationally. The company offers antiseptic creams, body lotions, soaps, aloe vera gels, petroleum jellies, prickly heat powders, and all-season creams under the BoroPlus brand; cool oils and talcs under the Navratna brand; ayurvedic products for pain management, immunity, digestive health, and bone and joint health, as well as pain balms, healthcare, generics, and ethical products under the Zandu brand; ayurvedic medicinal oils, shampoos, and conditioners under the Kesh King brand; and brightening creams, brightening face washes, and oil clear face washes for men under the Smart And Handsome brand. It also provides pain balms under the Emami Mentho Plus brand; light hair oils under the Emami 7 Oils in One brand; prickly heat powders and sprays, soaps, and shower gels under the Dermicool brand; German skincare products under the Creme 21 brand; deodorants, eau de toilettes, shampoos, face and body washes, and shower gels under the HE brand; body sprays and perfumes, as well as face, hair, body, beard, and shaving products under The Man Company brand; and face…
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 904 | 799 | 1,152 | 925 | 1,039 |
| Operating profit | 214 | 179 | 384 | 187 | 226 |
| Net profit | 164 | 148 | 319 | 143 | 137 |
| EPS (₹) | 3.76 | 3.40 | 7.32 | 3.28 | 3.15 |
Concall summary (2026-08-10)
AI summary of the earnings call transcript · tone: Positive · source document
Guidance & outlook
- We have used this period to strengthen market fundamentals, improve pricing architecture and enhance operational agility and remain confident of progressively regaining momentum and delivering healthy growth in the coming quarters.
- We are enhancing supply chain planning, inventory management and distribution visibility, which will help improve forecast accuracy, service levels and working capital efficiency.
Growth & demand
- Our domestic business grew by 20% and on a like -to-like basis, growth stood at a healthy 12% with a volume growth of 8% after considering the previous year numbers of two of our start-ups, Axiom and IncNut.
- On a like-to-like basis, this portfolio grew by an impressive 61%, which now contributes 18% of our domestic business, highlighting the increasing relevance of our new age growth engine.
Margins & costs
- On profitability, the quarter witnessed inflationary pressures led by higher crude oil prices and sustained cost increases across packaging material. making it one of the challenging cost environment for the sector in recent years.
- While we undertook measured price increases to mitigate the impact of cost inflation, the sharp rise in input costs during the quarter weighed on profitability.
Capex & expansion
- We are equally encouraged by the performance of our recently acquired businesses.
- These factors, together with the changing business mix following the integration of the acquired businesses, resulting in higher COGS and moderation in gross margin compared to last year.
Balance sheet & cash
- Vaibhav, it includes a dividend from one of our international subsidiaries amounting to roughly INR32 crores, so which gets knocked off in consolidation.
- I think the Rosemary oil shorts are really paying dividends for us and consumers are very happy with that product.
Peers in Household & Personal Products
Data for information only, not investment advice. Prices end of day.